LGX818

LGX818 (Encorafenib) is a highly potent RAF inhibitor with selective anti-proliferative and apoptotic activity in cells expressing B-RAF(V600E) with EC50 of 4 nM.


Cat. No.: EX-A1587	Purity: >99%

	Chemical structure of LGX818

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
250mg	285	In-stock
500mg	435	In-stock
1g	725	In-stock
2g	1200	In-stock
5g	2625	In-stock
10g	3925	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	Encorafenib
CAS No.	1269440-17-6
Purity	>99%
Formula	C22H27ClFN7O4S
Mol Weight	540.011
State	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Li Z, et al. Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cells. Cancer Lett. 2016 Jan 28;370(2):332-44. [2]. Compounds and compositions as protein kinase inhibitors . Patent WO 2011025927 A1 [3]. Stuart D D, Li N, Poon D J, et al. Preclinical profile of LGX818: A potent and selective RAF kinase inhibitor. Cancer Research, 2012, 72(8 Supplement): 3790.
CoA	CoA of LGX818

Smiles:	COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C


		Search